Brad McElya, Pharm.D., on Preparation of a Drug Pipeline Talk. It Involves a 'Ton of Research' | Asembia's AXS25 Summit
In an interview with Managed Healthcare Executive, Brad McElya, Pharm.D., senior director, clinical pharmacy, at Walgreens, discusses the preparation that went into the drug pipeline talk he gave today at Asembia's AXS25 Summit in Las Vegas. McElya said his review about late-stage drug development would cover 140 drugs. He said he works with a team of six therapeutic area experts and also broader clinical teams at Walgreens. Preparing the talk involves a "ton of research," he said, that includes spending a lot of time on pharmaceutical company earnings calls. McElya emphasized the primacy of the patient. "It starts for us with the patient, understanding the unique needs of the patients and then, within that, the overall therapeutic area."
GLP-1 Tiering Agreement Reached, Says Optum Rx President
May 3rd 2024Health plans that use Optum Rx as their pharmacy benefit manager (PBM) will be allowed to tier their coverage of GLP-1s and still receive rebates under an agreement the PBM has reached with the manufacturers, says the PBM president. Optum officials said later that the negotiations were still ongoing,
Read More
Specialty Pharmacies Drive Cost Savings in Value-Based Care | Asembia 2024
May 2nd 2024Earlier this week at the 2024 Asembia Specialty Pharmacy Summit in Las Vegas, Managed Healthcare Executive editors spoke with Bill McElnea, vice president of population health at Shields Health Solutions, about specialty pharmacies reducing costs for patients.
Read More
